🚀

오늘의 열정을 계속 이어가세요!

체험은 만족하셨나요? 지식 자료를 소장하고 멋진 의료인으로 성장하세요!

구경하기
β-Adrenergic Blocker Eye Medications | 마이메르시 MyMerci
제안하기

뭔가 하고 싶은 말이 있는거야?

제안하기
닫기
컨텐츠 수정하기

컨텐츠 내용을 수정할 수 있습니다

수정하기
닫기

β-Adrenergic Blocker Eye Medications

NCLEX Review Guide: β-Adrenergic Blocker Eye Medications

Overview of β-Adrenergic Blocker Eye Medications

Mechanism of Action

  • β-Adrenergic blockers work by blocking beta-adrenergic receptors in the eye, which reduces aqueous humor production and decreases intraocular pressure (IOP).
  • These medications are primarily used to treat glaucoma and ocular hypertension by improving aqueous humor outflow.

Memory Aid: "BETA BLOCKS PRESSURE"

Beta blockers Block aqueous humor production → Pressure drops

Key Points

  • Primary action: Decrease aqueous humor production
  • Main indication: Open-angle glaucoma and ocular hypertension
  • Route: Topical ophthalmic drops

Common β-Adrenergic Blocker Eye Medications

Primary Medications

  • Timolol (Timoptic) - Most commonly used, non-selective beta blocker with twice daily dosing.
  • Betaxolol (Betoptic) - Selective β1-blocker, safer for patients with respiratory conditions.
  • Levobunolol (Betagan) - Non-selective beta blocker with once or twice daily dosing.
  • Carteolol (Ocupress) - Non-selective beta blocker with intrinsic sympathomimetic activity.

Selective vs Non-Selective Beta Blockers

Selective (β1)Non-Selective (β1 & β2)
BetaxololTimolol, Levobunolol
Safer for COPD/AsthmaHigher risk respiratory effects
Less systemic effectsMore systemic absorption

Nursing Considerations & Administration

Pre-Administration Assessment

  • Assess for contraindications including asthma, COPD, heart block, and bradycardia before administration.
  • Obtain baseline vital signs, particularly heart rate and blood pressure, as systemic absorption can occur.
  • Check current medications for interactions with oral beta blockers or calcium channel blockers.

    Proper Administration Technique

  1. Wash hands thoroughly before handling eye drops
  2. Tilt patient's head back and pull down lower eyelid
  3. Instill prescribed number of drops into conjunctival sac
  4. Apply gentle pressure to nasolacrimal duct for 1-2 minutes to prevent systemic absorption
  5. Wait 5 minutes between different eye medications

Clinical Scenario

A 65-year-old patient with glaucoma and mild COPD is prescribed eye drops. The nurse should question an order for timolol and advocate for betaxolol due to its β1-selectivity and reduced respiratory risk.

Side Effects & Adverse Reactions

Local Side Effects

  • Ocular irritation, burning, and stinging are common immediately after instillation.
  • Decreased tear production may lead to dry eyes and increased risk of corneal damage.
  • Blurred vision and photophobia may occur, especially during initial treatment period.

Systemic Side Effects

  • Bradycardia and hypotension can occur due to systemic absorption, especially with non-selective agents.
  • Bronchospasm risk in patients with asthma or COPD, particularly with non-selective beta blockers.
  • Fatigue, dizziness, and depression may develop with chronic use due to systemic effects.

Memory Aid: "BETA Side Effects"

Bradycardia, Eye irritation, Tear reduction, Asthma exacerbation

Patient Education & Safety

Essential Patient Teaching

  • Instruct patients to apply nasolacrimal pressure after instillation to minimize systemic absorption and side effects.
  • Emphasize the importance of not discontinuing medication abruptly to prevent rebound increase in intraocular pressure.
  • Teach proper storage techniques, keeping medications at room temperature and protecting from light.
  • Advise patients to report any respiratory difficulties, especially those with history of asthma or COPD.

Patient Teaching Scenario

A patient asks why they need to press on their tear duct after using eye drops. The nurse explains this prevents the medication from draining into the nose and being absorbed systemically, reducing the risk of heart and lung side effects.

Key Points

  • Always assess respiratory status before administration
  • Nasolacrimal pressure is crucial for safety
  • Monitor for systemic beta-blocker effects
  • Selective β1-blockers are safer for respiratory patients

Commonly Confused Concepts

β-Blockers vs Other Glaucoma Medications

β-BlockersProstaglandin AnalogsCarbonic Anhydrase Inhibitors
Decrease aqueous productionIncrease aqueous outflowDecrease aqueous production
Systemic cardiac effectsIris color changesSystemic metabolic effects
Contraindicated in asthmaSafe in respiratory diseaseContraindicated in sulfa allergy

Quick Check: Common Pitfalls

  • ❌ Forgetting to assess respiratory status before β-blockers
  • ❌ Not teaching nasolacrimal pressure technique
  • ❌ Confusing selective vs non-selective properties
  • ✅ Always check for asthma/COPD before administration

Self-Assessment

Quick Knowledge Check

  • ☐ I can identify the mechanism of action of β-adrenergic blocker eye drops
  • ☐ I understand the difference between selective and non-selective β-blockers
  • ☐ I can teach proper administration technique including nasolacrimal pressure
  • ☐ I know the contraindications and when to question orders
  • ☐ I can recognize and respond to adverse effects

NCLEX Alert

Remember: β-adrenergic blocker eye drops can cause systemic effects. Always assess respiratory and cardiac status, and teach patients proper administration techniques to minimize absorption!

You're mastering complex pharmacology concepts! Understanding β-adrenergic blocker eye medications shows your growing expertise in safe medication administration. Keep studying with confidence - you're preparing to provide excellent patient care!

다음 이론을 계속 학습하려면 로그인하세요.

로그인하고 계속 학습
컨텐츠를 그만볼래?

필기노트, 하이라이터, 메모는 잘 쓰고 있어?

내보내줘
어떤 폴더에 저장할래?

컨텐츠 노트에는 총 0개의 폴더가 있어!

폴더 만들기
컨텐츠 만들기
만들기
신고했어요.

운영진이 검토할게요!

해당 유저를 차단했어요.

마이페이지에서 차단한 회원을 관리할 수 있어요.